Advances in research and clinical decision strategies for anticoagulation timing in acute ischemic stroke patients with atrial fibrillation.
Current evidence supports a shift from fixed delay rules toward individualized anticoagulation strategies, and clinical decision-making should integrate stroke severity, neuroimaging findings, and individual thromboembolic and bleeding risks.